5-Hydroxytryptamine-3 Antagonists: A New Class of Potent Antiemetics in Cancer Therapy
1991; Springer Science+Business Media; Linguagem: Inglês
10.1007/978-3-642-84138-5_10
ISSN2197-6767
Autores Tópico(s)Pharmacological Effects and Toxicity Studies
ResumoFor many years nausea and vomiting have been recognized as side-effects of numerous chemotherapeutic regimens. The development of the useful new agent cisplatin, due with its powerful emetic effect, highlighted this patient problem.
Referência(s)